Nanosonics (NNCSF) Projected to Post Earnings on Tuesday

Nanosonics (OTCMKTS:NNCSF) is expected to be posting its results before the market opens on Tuesday, February 24th. Analysts expect Nanosonics to post earnings of $0.0209 per share and revenue of $69.7850 million for the quarter.

Nanosonics Stock Performance

Shares of NNCSF opened at $2.65 on Friday. The stock has a 50 day moving average price of $2.72 and a 200 day moving average price of $2.73. Nanosonics has a one year low of $2.30 and a one year high of $3.30.

Analyst Upgrades and Downgrades

Separately, Royal Bank Of Canada raised shares of Nanosonics from an “underperform” rating to a “sector perform” rating in a report on Monday, January 19th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has an average rating of “Hold”.

About Nanosonics

Nanosonics Limited is an Australia‐based medical technology company specializing in infection prevention solutions for the healthcare sector. Founded in 2001 and headquartered in Sydney, the company is best known for developing and commercializing its proprietary Trophon platform, which provides automated high‐level disinfection of ultrasound probes using sonically activated hydrogen peroxide vapor. Nanosonics holds numerous patents and regulatory approvals across multiple jurisdictions, positioning it as a leader in point‐of‐care decontamination.

The company’s flagship product, Trophon EPR, is designed to address the critical need for rapid, reliable disinfection of endocavity and surface ultrasound transducers.